Study on behavioral AI to predict and increase peritoneal dialysis use
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses behavioral AI to help predict and encourage use of peritoneal dialysis in patients with advanced chronic kidney disease (stages 4-5). It aims to understand what factors influence decision-making and improve access to this treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have chronic kidney disease stage 4 or 5.
- You must live in the United States or the United Kingdom.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates whether MyRenalCare, a digital platform that helps patients with chronic kidney disease (CKD) monitor and manage their condition, improves health outcomes and patient experience. Researchers will compare people using the platform with those receiving standard care, and interview patients and staff about their experiences.
This study helps people with advanced chronic kidney disease explore their care options, including the choice to manage without dialysis. It provides support and information to help you and your family make a decision that fits your values.
This study uses artificial intelligence to analyze electronic health records and predict how well dialysis is working. If you've been on dialysis for at least 3 months, your data could help improve future care.
This study tests whether a special AI tool can help doctors make better decisions about peritoneal dialysis (a type of kidney treatment). You will use the AI to answer clinical scenarios and your answers will be compared to others.
This study watches how well a certain method (percutaneous) works for placing a peritoneal dialysis (PD) catheter, which is a soft tube used for a type of kidney dialysis. By tracking patients’ experiences before and after the procedure, the study aims to improve care for people with kidney failure.
This trial tests a specialized artificial intelligence tool designed to help doctors and residents manage peritoneal dialysis (a kidney treatment where fluid is exchanged through the abdomen). Researchers want to see if the AI tool can help healthcare providers improve their decision-making and care for patients on this treatment.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.